放射線誘導(dǎo)BRCA1出核效應(yīng)對PARP抑制劑的增敏作用
[Abstract]:Objective to investigate the effect of radiation-induced nucleation of breast cancer gene 1 (BRCA1) on the repair function of (DSB) induced by homologous recombination of DNA double strand break and to enhance the sensitivity of polyadenosine diphosphate ribose polymerase (PARP) inhibitor. Methods the subcellular localization of BRCA1 in breast cancer cell line MCF7 was detected by subcellular purification and Western blotting. Meanwhile, nuclear phosphorylation of H2AX histone (緯-H2AX) and nuclear focus formation of Rad51 were detected by immunofluorescence. Flow cytometry was used to detect cell apoptosis and clone formation assay was used to detect cell survival in vitro. The nude mice were divided into 4 groups: control group, radiation DMSO group, pseudoradiographic ABT-888 (ABT-888 as PARP inhibitor) group. ABT-888 group was given 2 Gy irradiation or false irradiation every 5 days. A total of 4 cycles of treatment were given on day 2 to day 5: solvent (control group, radiation DMSO group) or 20 mg/ (kg d) ABT-888 (pseudoradiographic ABT-888 group). The inhibitory effect in vivo of each group was detected. Results after 4 Gy irradiation, the expression of BRCA1 in the nucleus of MCF7 was decreased to 41% of that in the control group, but the expression of BRCA1 in the cytoplasm was significantly increased. At the same time, the number of Rad51 focus forming positive cells induced by ABT-888 in MCF7 cells after 4 Gy irradiation was significantly lower than that in the control group (7vs.30). The apoptosis rate of MCF7 cells was increased by radiation combined with ABT-888 (19%), which was significantly higher than that of control group (5%), radiation DMSO group (9%) or pseudoradiographic ABT-888 group (6.2%) (P0.01). In nude mice, the inhibitory effect of radiation ABT-888 on tumor growth was significantly better than that of DMSO or ABT-888 (P0.01). Conclusion radiation can induce the nucleation of BRCA1 and enhance the anti-tumor effect of PARP inhibitor.
【作者單位】: 廣州醫(yī)科大學(xué)附屬第一醫(yī)院呼吸疾病國家重點實驗室 廣州呼吸疾病研究所;廣州醫(yī)科大學(xué)附屬第一醫(yī)院病理科;
【基金】:國家自然科學(xué)基金資助項目(編號:81272901) 廣州市醫(yī)藥衛(wèi)生科技項目(編號:20151A011067)
【分類號】:R737.9
【相似文獻】
相關(guān)期刊論文 前10條
1 周冬仙;熊文;徐紅先;邵超鵬;;A Novel Frequent BRCA1 Allele in Chinese Patients with Breast Cancer[J];華中科技大學(xué)學(xué)報(醫(yī)學(xué)英德文版);2006年05期
2 任婕;魏敏杰;金鋒;楊棟;林哲珠;馬文峰;金萬寶;;散發(fā)性乳腺癌組織中BRCA1基因啟動子甲基化與蛋白表達(dá)的相關(guān)性[J];中華腫瘤防治雜志;2007年03期
3 Rajasekaran R;George Priya Doss;Sudandiradoss C;Ramanathan K;Rituraj Purohit;Rao Sethumadhavan;;Computational and Structural Investigation of Deleterious Functional SNPs in Breast Cancer BRCA2 Gene[J];生物工程學(xué)報;2008年05期
4 任婕;王麟;馬文峰;米小軼;馮婉玉;金萬寶;魏敏杰;;BRCA1和相關(guān)凋亡調(diào)控蛋白在人乳腺浸潤性導(dǎo)管癌中的表達(dá)與相關(guān)性分析[J];現(xiàn)代腫瘤醫(yī)學(xué);2008年08期
5 易韋;文安智;;BRCA_1在散發(fā)性乳腺浸潤性導(dǎo)管癌癌組織中的表達(dá)及意義[J];山東醫(yī)藥;2008年26期
6 董蕾;李文才;;人BRCA1真核表達(dá)載體的構(gòu)建及鑒定[J];山東醫(yī)藥;2009年51期
7 王辛;熊靜波;黎相照;褚紅娟;張弓;楊建芳;趙彤;;散發(fā)性乳腺浸潤性導(dǎo)管癌中BRCA1表達(dá)及臨床意義[J];中國腫瘤臨床;2009年02期
8 張永平;趙虎;韋伊芳;張健;藥立波;;人BRCA1干涉慢病毒載體的構(gòu)建與驗證[J];現(xiàn)代生物醫(yī)學(xué)進展;2012年17期
9 范q,
本文編號:2289315
本文鏈接:http://sikaile.net/yixuelunwen/waikelunwen/2289315.html